Bittner, Stefan; Ruck, Tobias; Wiendl, Heinz et al.
Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical managementTHERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. Bd. 10. H. 1. 2017 S. 51-66
Czeredys, Magdalena; Maciag, Filip; Methner, Axel et al.
Tetrahydrocarbazoles decrease elevated SOCE in medium spiny neurons from transgenic YAC128 mice, a model of Huntington's diseaseBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. Bd. 483. H. 4. 2017 S. 1194-1205
Cerina, Manuela; Narayanan, Venu; Goebel, Kerstin et al.
The quality of cortical network function recovery depends on localization and degree of axonal demyelinationBRAIN BEHAVIOR AND IMMUNITY. Bd. 59. 2017 S. 103-117
Kalisch, Raffael; Baker, Dewleen G.; Basten, Ulrike et al.
The resilience framework as a strategy to combat stress-related disordersNATURE HUMAN BEHAVIOUR. Bd. 1. H. 11. 2017 S. 784-790
Birkner, Katharina; Wasser, Beatrice; Loos, Julia et al.
The Role of ERK Signaling in Experimental Autoimmune EncephalomyelitisINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 18. H. 9. 2017
Baron, R.; Treede, R. D.; Birklein, F. et al.
Treatment of painful radiculopathies with capsaicin 8% cutaneous patchCURRENT MEDICAL RESEARCH AND OPINION. Bd. 33. H. 8. 2017 S. 1401-1411
Muthuraman, Muthuraman; Hartwigsen, Gesa; Groppa, Sergiu
(Non-) invasive mapping of cortical language areasCLINICAL NEUROPHYSIOLOGY. Bd. 127. H. 3. 2016 S. 1762-1763
Droby, Amgad; Panagoulias, Michail; Albrecht, Philipp et al.
A novel automated segmentation method for retinal layers in OCT images proves retinal degeneration after optic neuritisBRITISH JOURNAL OF OPHTHALMOLOGY. Bd. 100. H. 4. 2016 S. 484-490
Lukas, C.; Gold, R.; Fiehler, J. et al.
Accumulation of Gadolinium-based Contrast Agents in the Brain Due to Repetitive Contrast-enhanced MRI: Implications for the Use of MRI in the Diagnosis and Follow-up of Multiple Sclerosis Patients?AKTUELLE NEUROLOGIE. Bd. 43. H. 4. 2016 S. 237-241
Bittner, S.; Meuth, S. G.
Actual medical care situation and therapeutic needs in multiple sclerosis. Impact of the Pharmaceutical Market Restructuring Act (AMNOG)NERVENARZT. Bd. 87. H. 4. 2016 S. 394-401